Volume 15, Number 10—October 2009
Research
Nontuberculous Mycobacteria–associated Lung Disease in Hospitalized Persons, United States, 1998–2005
Table 1
Group | Sex | Annual % change | Wald 95% CI | p value |
---|---|---|---|---|
State | ||||
California | M | –1.5 | –4.0–1.3 | 0.24 |
F | –1.5 | –3.3–0.3 | 0.10 | |
New York | M | –2.7 | –5.9–0.54 | 0.10 |
F | 4.5 | 1.1–8.2 | 0.0097 | |
Florida | M | 3.2 | 0.76–5.7 | 0.010 |
F |
6.3 |
3.1–9.9 |
0.00010 |
|
Age group, y | ||||
50–59 | M | –2.7 | –4.8 to –0.61 | 0.0118 |
F | 0.14 | –1.4–1.7 | 0.8629 | |
60–69 | M | –1.5 | –3.1–0.01 | 0.0490 |
F | 4.6 | 1.2–8.0 | 0.0069 | |
70–79 | M | 5.3 | 2.5–8.2 | 0.0001 |
F | 5.5 | 2.9–8.2 | <0.0001 | |
>80 | M | 0.65 | –3.0–4.4 | 0.7327 |
F | 2.5 | –0.62–5.7 | 0.1177 |
*NTM, nontuberculous mycobacteria; HCUP, Healthcare Cost and Utilization Project; SID, state inpatient databases; CI, confidence interval. The scaled Pearson χ2 (value/df) was 1 for all items.
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.